前立腺がん治療薬の世界市場 2021年:メーカー別、地域別、種類・用途別

【英語タイトル】Global Prostate Cancer Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが出版した調査資料(GIR21AR11554)・商品コード:GIR21AR11554
・発行会社(調査会社):GlobalInfoResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:138
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2~3日)
・調査対象地域:グローバル
・産業分野:医療・医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
GlobalInfoResearch社の本調査レポートでは、前立腺がん治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。前立腺がん治療薬の種類別市場規模(ホルモン療法、化学療法、免疫療法、標的療法)、用途別市場規模(クリニック、病院、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):AbbVie、Astellas Pharma、Astra Zeneca、Johnson & Johnson、Sanofi、GlaxoSmithKline、Merck Group、Novartis、Amgen、Bayer HealthCare、Ferring Pharmaceutical、Janssen Pharmaceuticals、Endo Pharmaceuticals、BMS、Takeda Pharmaceuticals、Northwest Biotherapeutics、Teva Pharmaceutical、Boehringer Ingelheim、Foresee Pharmaceuticals、Tokai Pharmaceuticals、Spectrum Pharmaceuticals
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ホルモン療法、化学療法、免疫療法、標的療法
・用途別分析2016年-2026年:クリニック、病院、その他
・前立腺がん治療薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・前立腺がん治療薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・前立腺がん治療薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・前立腺がん治療薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・前立腺がん治療薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Prostate Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Prostate Cancer Drugs size is estimated to be xx million in 2020 from USD 6256 million in 2019, with a change of XX% between 2019 and 2020. The global Prostate Cancer Drugs market size is expected to grow at a CAGR of 6.2% for the next five years.

Market segmentation
Prostate Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy

Market segment by Application can be divided into
Clinics
Hospitals
Other

The key market players for global Prostate Cancer Drugs market are listed below:
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Prostate Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostate Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostate Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Prostate Cancer Drugs Market Size & Forecast
1.4.1 Global Prostate Cancer Drugs Sales in Value (2016-2026))
1.4.2 Global Prostate Cancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Prostate Cancer Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Prostate Cancer Drugs Production Capacity Analysis
1.5.1 Global Prostate Cancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Prostate Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate Cancer Drugs Market Drivers
1.6.2 Prostate Cancer Drugs Market Restraints
1.6.3 Prostate Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Prostate Cancer Drugs Product and Services
2.1.4 AbbVie Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business
2.2.3 Astellas Pharma Prostate Cancer Drugs Product and Services
2.2.4 Astellas Pharma Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Astra Zeneca
2.3.1 Astra Zeneca Details
2.3.2 Astra Zeneca Major Business
2.3.3 Astra Zeneca Prostate Cancer Drugs Product and Services
2.3.4 Astra Zeneca Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Prostate Cancer Drugs Product and Services
2.4.4 Johnson & Johnson Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Prostate Cancer Drugs Product and Services
2.5.4 Sanofi Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Prostate Cancer Drugs Product and Services
2.6.4 GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck Group
2.7.1 Merck Group Details
2.7.2 Merck Group Major Business
2.7.3 Merck Group Prostate Cancer Drugs Product and Services
2.7.4 Merck Group Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Prostate Cancer Drugs Product and Services
2.8.4 Novartis Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Prostate Cancer Drugs Product and Services
2.9.4 Amgen Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Bayer HealthCare
2.10.1 Bayer HealthCare Details
2.10.2 Bayer HealthCare Major Business
2.10.3 Bayer HealthCare Prostate Cancer Drugs Product and Services
2.10.4 Bayer HealthCare Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Ferring Pharmaceutical
2.11.1 Ferring Pharmaceutical Details
2.11.2 Ferring Pharmaceutical Major Business
2.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Product and Services
2.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Janssen Pharmaceuticals
2.12.1 Janssen Pharmaceuticals Details
2.12.2 Janssen Pharmaceuticals Major Business
2.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Product and Services
2.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Endo Pharmaceuticals
2.13.1 Endo Pharmaceuticals Details
2.13.2 Endo Pharmaceuticals Major Business
2.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Product and Services
2.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 BMS
2.14.1 BMS Details
2.14.2 BMS Major Business
2.14.3 BMS Prostate Cancer Drugs Product and Services
2.14.4 BMS Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Takeda Pharmaceuticals
2.15.1 Takeda Pharmaceuticals Details
2.15.2 Takeda Pharmaceuticals Major Business
2.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Product and Services
2.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Northwest Biotherapeutics
2.16.1 Northwest Biotherapeutics Details
2.16.2 Northwest Biotherapeutics Major Business
2.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Product and Services
2.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Teva Pharmaceutical
2.17.1 Teva Pharmaceutical Details
2.17.2 Teva Pharmaceutical Major Business
2.17.3 Teva Pharmaceutical Prostate Cancer Drugs Product and Services
2.17.4 Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Boehringer Ingelheim
2.18.1 Boehringer Ingelheim Details
2.18.2 Boehringer Ingelheim Major Business
2.18.3 Boehringer Ingelheim Prostate Cancer Drugs Product and Services
2.18.4 Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Foresee Pharmaceuticals
2.19.1 Foresee Pharmaceuticals Details
2.19.2 Foresee Pharmaceuticals Major Business
2.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Product and Services
2.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Tokai Pharmaceuticals
2.20.1 Tokai Pharmaceuticals Details
2.20.2 Tokai Pharmaceuticals Major Business
2.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Product and Services
2.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Spectrum Pharmaceuticals
2.21.1 Spectrum Pharmaceuticals Details
2.21.2 Spectrum Pharmaceuticals Major Business
2.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Product and Services
2.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Prostate Cancer Drugs Sales by Manufacturer
3.1 Global Prostate Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Prostate Cancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Prostate Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Prostate Cancer Drugs Manufacturer Market Share
3.4.2 Top 6 Prostate Cancer Drugs Manufacturer Market Share
3.5 Global Prostate Cancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Prostate Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prostate Cancer Drugs Market Size by Region
4.1.1 Global Prostate Cancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Prostate Cancer Drugs Revenue by Region (2016-2026)
4.2 North America Prostate Cancer Drugs Revenue (2016-2026)
4.3 Europe Prostate Cancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Prostate Cancer Drugs Revenue (2016-2026)
4.5 South America Prostate Cancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Prostate Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Prostate Cancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Prostate Cancer Drugs Revenue by Type (2016-2026)
5.3 Global Prostate Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Prostate Cancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Prostate Cancer Drugs Revenue by Application (2016-2026)
6.3 Global Prostate Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Prostate Cancer Drugs Sales by Type (2016-2026)
7.2 North America Prostate Cancer Drugs Sales by Application (2016-2026)
7.3 North America Prostate Cancer Drugs Market Size by Country
7.3.1 North America Prostate Cancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Prostate Cancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Prostate Cancer Drugs Sales by Type (2016-2026)
8.2 Europe Prostate Cancer Drugs Sales by Application (2016-2026)
8.3 Europe Prostate Cancer Drugs Market Size by Country
8.3.1 Europe Prostate Cancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Prostate Cancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Prostate Cancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Prostate Cancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Prostate Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Prostate Cancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Prostate Cancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Prostate Cancer Drugs Sales by Type (2016-2026)
10.2 South America Prostate Cancer Drugs Sales by Application (2016-2026)
10.3 South America Prostate Cancer Drugs Market Size by Country
10.3.1 South America Prostate Cancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Prostate Cancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prostate Cancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Prostate Cancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Prostate Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Prostate Cancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Prostate Cancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Prostate Cancer Drugs Typical Distributors
12.3 Prostate Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Prostate Cancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Prostate Cancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Prostate Cancer Drugs Product and Services
Table 6. AbbVie Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Pharma Major Business
Table 9. Astellas Pharma Prostate Cancer Drugs Product and Services
Table 10. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 12. Astra Zeneca Major Business
Table 13. Astra Zeneca Prostate Cancer Drugs Product and Services
Table 14. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Prostate Cancer Drugs Product and Services
Table 18. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Prostate Cancer Drugs Product and Services
Table 22. Sanofi Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Prostate Cancer Drugs Product and Services
Table 26. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck Group Basic Information, Manufacturing Base and Competitors
Table 28. Merck Group Major Business
Table 29. Merck Group Prostate Cancer Drugs Product and Services
Table 30. Merck Group Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Prostate Cancer Drugs Product and Services
Table 34. Novartis Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Amgen Basic Information, Manufacturing Base and Competitors
Table 36. Amgen Major Business
Table 37. Amgen Prostate Cancer Drugs Product and Services
Table 38. Amgen Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 40. Bayer HealthCare Major Business
Table 41. Bayer HealthCare Prostate Cancer Drugs Product and Services
Table 42. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Ferring Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Ferring Pharmaceutical Major Business
Table 45. Ferring Pharmaceutical Prostate Cancer Drugs Product and Services
Table 46. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Janssen Pharmaceuticals Major Business
Table 49. Janssen Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 50. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Endo Pharmaceuticals Major Business
Table 53. Endo Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 54. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. BMS Basic Information, Manufacturing Base and Competitors
Table 56. BMS Major Business
Table 57. BMS Prostate Cancer Drugs Product and Services
Table 58. BMS Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Takeda Pharmaceuticals Major Business
Table 61. Takeda Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 62. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Northwest Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Northwest Biotherapeutics Major Business
Table 65. Northwest Biotherapeutics Prostate Cancer Drugs Product and Services
Table 66. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical Major Business
Table 69. Teva Pharmaceutical Prostate Cancer Drugs Product and Services
Table 70. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 72. Boehringer Ingelheim Major Business
Table 73. Boehringer Ingelheim Prostate Cancer Drugs Product and Services
Table 74. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Foresee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Foresee Pharmaceuticals Major Business
Table 77. Foresee Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 78. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Tokai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Tokai Pharmaceuticals Major Business
Table 81. Tokai Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 82. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. Spectrum Pharmaceuticals Major Business
Table 85. Spectrum Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 86. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Global Prostate Cancer Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 88. Global Prostate Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 89. Market Position of Manufacturers in Prostate Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 90. Global Prostate Cancer Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 91. Head Office and Prostate Cancer Drugs Production Site of Key Manufacturer
Table 92. Global Prostate Cancer Drugs Sales by Region (2016-2021e) & (K MT)
Table 93. Global Prostate Cancer Drugs Sales by Region (2021-2026) & (K MT)
Table 94. Global Prostate Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 95. Global Prostate Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 96. Global Prostate Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 97. Global Prostate Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 98. Global Prostate Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 99. Global Prostate Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 100. Global Prostate Cancer Drugs Price by Type (2016-2021e) & (USD/MT)
Table 101. Global Prostate Cancer Drugs Price by Type (2021-2026) & (USD/MT)
Table 102. Global Prostate Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 103. Global Prostate Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 104. Global Prostate Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 105. Global Prostate Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 106. Global Prostate Cancer Drugs Price by Application (2016-2021e) & (USD/MT)
Table 107. Global Prostate Cancer Drugs Price by Application (2021-2026) & (USD/MT)
Table 108. North America Prostate Cancer Drugs Sales by Country (2016-2021e) & (K MT)
Table 109. North America Prostate Cancer Drugs Sales by Country (2021-2026) & (K MT)
Table 110. North America Prostate Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. North America Prostate Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. North America Prostate Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 113. North America Prostate Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 114. North America Prostate Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 115. North America Prostate Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 116. Europe Prostate Cancer Drugs Sales by Country (2016-2021e) & (K MT)
Table 117. Europe Prostate Cancer Drugs Sales by Country (2021-2026) & (K MT)
Table 118. Europe Prostate Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 119. Europe Prostate Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 120. Europe Prostate Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 121. Europe Prostate Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 122. Europe Prostate Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 123. Europe Prostate Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 124. Asia-Pacific Prostate Cancer Drugs Sales by Region (2016-2021e) & (K MT)
Table 125. Asia-Pacific Prostate Cancer Drugs Sales by Region (2021-2026) & (K MT)
Table 126. Asia-Pacific Prostate Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 127. Asia-Pacific Prostate Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 128. Asia-Pacific Prostate Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 129. Asia-Pacific Prostate Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 130. Asia-Pacific Prostate Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 131. Asia-Pacific Prostate Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 132. South America Prostate Cancer Drugs Sales by Country (2016-2021e) & (K MT)
Table 133. South America Prostate Cancer Drugs Sales by Country (2021-2026) & (K MT)
Table 134. South America Prostate Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 135. South America Prostate Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 136. South America Prostate Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 137. South America Prostate Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 138. South America Prostate Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 139. South America Prostate Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 140. Middle East & Africa Prostate Cancer Drugs Sales by Country (2016-2021e) & (K MT)
Table 141. Middle East & Africa Prostate Cancer Drugs Sales by Country (2021-2026) & (K MT)
Table 142. Middle East & Africa Prostate Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 143. Middle East & Africa Prostate Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 144. Middle East & Africa Prostate Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 145. Middle East & Africa Prostate Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 146. Middle East & Africa Prostate Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 147. Middle East & Africa Prostate Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Prostate Cancer Drugs Typical Distributors
Table 151. Prostate Cancer Drugs Typical Customers
List of Figures
Figure 1. Prostate Cancer Drugs Picture
Figure 2. Global Prostate Cancer Drugs Sales Market Share by Type in 2020
Figure 3. Hormonal Therapy
Figure 4. Chemotherapy
Figure 5. Immunotherapy
Figure 6. Targeted Therapy
Figure 7. Global Prostate Cancer Drugs Sales Market Share by Application in 2020
Figure 8. Clinics
Figure 9. Hospitals
Figure 10. Other
Figure 11. Global Prostate Cancer Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Prostate Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Prostate Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Prostate Cancer Drugs Sales (2016-2026) & (K MT)
Figure 33. Global Prostate Cancer Drugs Production Capacity (2016-2026) & (K MT)
Figure 34. Global Prostate Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Prostate Cancer Drugs Market Drivers
Figure 36. Prostate Cancer Drugs Market Restraints
Figure 37. Prostate Cancer Drugs Market Trends
Figure 38. Global Prostate Cancer Drugs Sales Market Share by Manufacturer in 2020
Figure 39. Global Prostate Cancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 40. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Prostate Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Prostate Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Prostate Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 44. Global Prostate Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 45. North America Prostate Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Prostate Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Prostate Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 48. South America Prostate Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Prostate Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Global Prostate Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 51. Global Prostate Cancer Drugs Revenue Market Share by Type (2016-2026)
Figure 52. Global Prostate Cancer Drugs Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Prostate Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 54. Global Prostate Cancer Drugs Revenue Market Share by Application (2016-2026)
Figure 55. Global Prostate Cancer Drugs Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Prostate Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 57. North America Prostate Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 58. North America Prostate Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Prostate Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 60. Europe Prostate Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 61. Europe Prostate Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Prostate Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Prostate Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Prostate Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Prostate Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America Prostate Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 70. South America Prostate Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Prostate Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Prostate Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source


【掲載企業】

AbbVie、Astellas Pharma、Astra Zeneca、Johnson & Johnson、Sanofi、GlaxoSmithKline、Merck Group、Novartis、Amgen、Bayer HealthCare、Ferring Pharmaceutical、Janssen Pharmaceuticals、Endo Pharmaceuticals、BMS、Takeda Pharmaceuticals、Northwest Biotherapeutics、Teva Pharmaceutical、Boehringer Ingelheim、Foresee Pharmaceuticals、Tokai Pharmaceuticals、Spectrum Pharmaceuticals

★調査レポート[前立腺がん治療薬の世界市場 2021年:メーカー別、地域別、種類・用途別] (コード:GIR21AR11554)販売に関する免責事項を必ずご確認ください。
★調査レポート[前立腺がん治療薬の世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆